Causes and Risk Factors for Gestational Trophoblastic Disease
Gestational Trophoblastic Disease (GTD) is a rare group of conditions that involve the abnormal growth of cells that form in the uterus after conception. These cells, called trophoblasts, normally develop into the placenta. Understanding the underlying mechanisms and predisposing factors is crucial for early diagnosis and effective management.

Key Takeaways
- GTD originates from abnormal trophoblast development, often linked to chromosomal errors during fertilization.
- Molar pregnancies (hydatidiform moles) are the most common precursors to GTD, with complete moles carrying a higher risk of progression.
- Key risk factors include maternal age extremes (under 20 or over 35), a history of previous molar pregnancies, and certain ethnic or geographic predispositions.
- While specific environmental or lifestyle causes of GTD in pregnancy are not fully established, genetic and reproductive factors play a significant role.
- Early recognition of risk factors for GTD is vital for timely intervention and improved patient outcomes.
Understanding Gestational Trophoblastic Disease Causes
What causes gestational trophoblastic disease? At its core, GTD arises from errors during fertilization, leading to the abnormal proliferation of trophoblastic cells. These cells, which would normally form the placenta, instead grow uncontrollably, often without a viable fetus. The fundamental issue lies in chromosomal abnormalities, where there is either an incorrect number of chromosomes or an abnormal set of chromosomes in the fertilized egg.
The most common form of GTD is a molar pregnancy, also known as a hydatidiform mole. In a complete molar pregnancy, an egg with no genetic material is fertilized by one or two sperm, resulting in a mass of placental tissue with no fetal development. In a partial molar pregnancy, a normal egg is fertilized by two sperm, leading to an embryo with too many chromosomes, which is usually abnormal and non-viable, alongside abnormal placental tissue. These genetic errors are the primary gestational trophoblastic disease causes, setting the stage for the potential development of more aggressive forms of GTD, such as choriocarcinoma or invasive moles.
Primary Risk Factors for GTD Development
While the exact triggers for these genetic anomalies are not always clear, several factors have been identified that increase an individual’s susceptibility to developing GTD. Understanding risk factors for gestational trophoblastic disease is essential for identifying individuals who may be at higher risk and ensuring appropriate monitoring. These factors do not directly cause the disease but are associated with an elevated likelihood of its occurrence.
Who is at risk for gestational trophoblastic disease? The demographic profile of individuals affected by GTD often points to specific groups. For instance, women at the extremes of reproductive age, particularly those under 20 or over 35, show a higher incidence. Geographic and ethnic variations also play a role, with higher rates reported in certain Asian and Latin American populations compared to North America and Europe. A prior history of GTD is also a significant predictor, substantially increasing the risk of recurrence. These insights help paint a clearer picture of gestational trophoblastic disease causes and risks, guiding both research and clinical practice.
Maternal Age
Maternal age is one of the most consistently identified risk factors for GTD. Women who become pregnant at a very young age, typically under 20, or those over the age of 35, face an increased risk. This risk escalates significantly for women over 40, with some studies suggesting a 5- to 10-fold increase compared to women in their 20s and early 30s. The reasons behind this age-related risk are thought to be linked to the quality of eggs, which can decline with age, potentially leading to a higher incidence of chromosomal abnormalities during fertilization.
For example, data from the American College of Obstetricians and Gynecologists (ACOG) indicates that the incidence of complete molar pregnancy is approximately 1 in 1,000 to 1,200 pregnancies in North America, but this rate can be notably higher in older reproductive-aged women. This emphasizes the importance of considering age as a crucial factor when evaluating an individual’s potential for GTD development.
Prior Reproductive History
A history of previous molar pregnancy is arguably the strongest predictor of future GTD. Individuals who have experienced one molar pregnancy have a significantly elevated risk of having another, with recurrence rates estimated to be between 1% and 2%. This risk further increases with each subsequent molar pregnancy. For example, after two previous molar pregnancies, the risk of a third can be as high as 15% to 20%, according to studies cited by organizations like the National Institutes of Health (NIH). This highlights the need for close monitoring and counseling for individuals with such a history.
Other aspects of reproductive history, such as a history of miscarriage, may also be loosely associated, though the link is less direct and less significant than a prior molar pregnancy. The exact mechanisms by which a previous molar pregnancy predisposes an individual to future occurrences are still under investigation but are believed to involve persistent genetic or cellular predispositions.
Beyond age and prior history, other potential risk factors, though less consistently proven, include:
- Nutritional Deficiencies: Some studies have suggested a possible link between diets low in carotene (a form of Vitamin A) and animal fat, particularly in regions with high GTD incidence, but more definitive research is needed.
- Blood Type: Limited research has explored a potential association between certain blood types (e.g., A or B) and an increased risk, but this remains largely inconclusive.
- Immunological Factors: The role of the maternal immune system in recognizing and clearing abnormal trophoblastic tissue is an area of ongoing research, though not yet a defined risk factor.
Role of Molar Pregnancies in GTD Development
Molar pregnancies, or hydatidiform moles, are the most common and direct precursors to GTD. These abnormal pregnancies occur when there is an issue with the fertilization process, leading to the development of abnormal placental tissue. There are two main types: complete moles and partial moles, each with distinct genetic characteristics and varying risks of progressing to more serious forms of GTD.
In a complete molar pregnancy, the entire placenta is abnormal, and no fetal tissue is present. This occurs when an egg without genetic material is fertilized by one or two sperm, resulting in a diploid set of chromosomes that are entirely paternal in origin. Complete moles carry a higher risk of developing into persistent GTD, such as invasive mole or choriocarcinoma, with approximately 15-20% progressing to these malignant forms. This makes understanding gestational trophoblastic disease causes intrinsically linked to the pathology of molar pregnancies.
A partial molar pregnancy involves the presence of both some fetal tissue (which is typically abnormal and non-viable) and abnormal placental tissue. This usually results from a normal egg being fertilized by two sperm, leading to a triploid set of chromosomes (69, XXX or 69, XXY). The risk of progression to persistent GTD from a partial mole is significantly lower than that of a complete mole, estimated to be around 1-5%. The distinction between these two types of molar pregnancies is critical for prognosis and management, as it directly impacts the likelihood of developing more aggressive forms of GTD, further clarifying the complex interplay of gestational trophoblastic disease causes and risks.
The progression of a molar pregnancy to persistent GTD involves the continued growth of abnormal trophoblastic tissue after the evacuation of the mole. This can manifest as an invasive mole, where the abnormal cells invade the uterine wall, or as choriocarcinoma, a highly malignant form of GTD that can metastasize to distant sites. Regular follow-up and monitoring of human chorionic gonadotropin (hCG) levels are crucial after a molar pregnancy to detect any such progression early.
Frequently Asked Questions
What is the primary underlying cause of GTD?
The primary underlying cause of Gestational Trophoblastic Disease (GTD) is abnormal fertilization, leading to chromosomal errors. This results in the uncontrolled growth of trophoblastic cells, which normally form the placenta. These genetic abnormalities prevent normal fetal development and instead produce abnormal placental tissue, most commonly seen in molar pregnancies. The errors can range from an egg lacking genetic material to an egg fertilized by two sperm, creating an incorrect chromosomal count.
Who is most susceptible to developing GTD?
Individuals at the extremes of reproductive age are most susceptible to developing GTD. This includes women under 20 years old and those over 35, with the risk significantly increasing for women over 40. A history of a previous molar pregnancy is also a very strong risk factor, increasing the likelihood of recurrence. Additionally, certain geographic and ethnic populations, particularly in Asia and Latin America, have shown a higher incidence of GTD.
How does a molar pregnancy relate to GTD?
Molar pregnancies are the most common and direct precursors to Gestational Trophoblastic Disease. They are considered a form of GTD themselves. In a molar pregnancy, abnormal placental tissue grows in the uterus due to fertilization errors. While many molar pregnancies resolve after removal, a significant percentage, especially complete moles, can progress to more aggressive forms of GTD, such as invasive moles or choriocarcinoma. Thus, molar pregnancies are a key initial manifestation and a major risk factor for subsequent GTD development.



















